| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.79B | +12.6% | +31.7% |
| Cost of Revenue | $262.8M | +10.5% | +19.6% |
| Gross Profit | $1.52B | +13.0% | +34.1% |
| R&D Expense | $927.0M | +12.2% | +35.3% |
| SG&A Expense | $214.5M | +10.9% | +27.4% |
| Operating Income | -$56.3M | -17.9% | -351.9% |
| Pre-tax Income | -$62.8M | -12.6% | -753.9% |
| Income Tax | $35.6M | +371.5% | -43.9% |
| Net Income | -$98.4M | -130.7% | -39.0% |
| EPS (Basic) | -$0.38 | -137.5% | -40.7% |
| EPS (Diluted) | -$0.38 | -137.5% | -40.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.14B | -1.9% | -57.3% |
| Short-term Investments | $0 | -100.0% | -100.0% |
| Accounts Receivable | $907.4M | -0.5% | +41.3% |
| Current Assets | $2.33B | -15.9% | -38.2% |
| Total Assets | $5.65B | -8.3% | -4.0% |
| Current Liabilities | $3.32B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $567.5M | +219.2% | -13.1% |
| Capital Expenditures | $6.2M | -33.1% | -56.8% |
| Investing Cash Flow | $404.1M | +135.3% | +625.1% |
| Financing Cash Flow | -$990.9M | -401.9% | -637.8% |
| Free Cash Flow | $561.3M | +233.1% | -12.1% |
| +11.1% |
| Long-term Debt | $989.1M | +0.0% | +0.2% |
| Total Liabilities | $4.77B | +4.4% | +5.7% |
| Stockholders' Equity | $879.0M | -44.7% | -35.8% |